Tantleff Quoted in Digiday About How the CCPA Will Impact Advertising
December 9, 2019
Digiday
Partner Aaron Tantleff was quoted in the Digiday article, ‘We’re not going to play around’: Ad industry grapples with California’s ambiguous privacy law,” about how many businesses are still grappling with what the California Consumer Privacy Act requires of their advertising practices.
While the California attorney general’s office is expected to clarify enforcement rules, many companies are taking conservative initial approaches to ensure they are compliant with the law by pulling back on targeted advertising and adopting limits on what they do with the data they receive from other companies.
“Digital advertisers use a variety of types of information that may be personal and is exchanged with other companies in order to fulfill their purpose or their services. Whether that meets the definition of sale under CCPA is questionable in some cases,” said Tantleff.
While the California attorney general’s office is expected to clarify enforcement rules, many companies are taking conservative initial approaches to ensure they are compliant with the law by pulling back on targeted advertising and adopting limits on what they do with the data they receive from other companies.
“Digital advertisers use a variety of types of information that may be personal and is exchanged with other companies in order to fulfill their purpose or their services. Whether that meets the definition of sale under CCPA is questionable in some cases,” said Tantleff.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."